CN Stock MarketDetailed Quotes

300391 Changjiang Pharmaceutical Group

Watchlist
  • 5.26
  • -0.25-4.54%
Market Closed Dec 30 15:00 CST
1.84BMarket Cap-2.75P/E (TTM)

Changjiang Pharmaceutical Group Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-90.12%101M
-84.53%73.65M
-56.80%59.09M
-25.86%1.2B
-28.17%1.02B
-52.01%476.01M
-74.92%136.79M
-31.61%1.62B
-21.76%1.42B
-23.56%991.85M
Operating revenue
-90.12%101M
-84.53%73.65M
-56.80%59.09M
-25.86%1.2B
-28.17%1.02B
-52.01%476.01M
-74.92%136.79M
-31.61%1.62B
-21.76%1.42B
-23.56%991.85M
Other operating revenue
----
-61.43%2.15M
----
47.17%8.15M
----
74.25%5.58M
----
-59.75%5.54M
----
-59.30%3.2M
Total operating cost
-77.19%230.25M
-65.33%164.29M
-44.39%89.75M
-20.61%1.18B
-21.40%1.01B
-47.82%473.82M
-66.56%161.38M
-29.73%1.49B
-20.04%1.28B
-20.11%908.11M
Operating cost
-88.82%96.03M
-82.52%69.48M
-56.54%54.6M
-21.05%1B
-22.29%859.11M
-47.99%397.4M
-69.17%125.65M
-30.53%1.27B
-21.06%1.11B
-23.38%764.04M
Operating tax surcharges
-16.73%2.01M
-27.81%1.25M
-15.94%554.83K
-47.23%3.71M
-56.84%2.41M
-61.37%1.73M
-69.00%660.02K
-18.46%7.03M
-16.09%5.59M
-0.98%4.48M
Operating expense
-47.45%13.04M
-4.12%9.4M
7.63%5.1M
-29.04%23.59M
-20.04%24.82M
-61.33%9.81M
-67.60%4.74M
-48.32%33.24M
-38.38%31.04M
-19.18%25.36M
Administration expense
-11.35%52.78M
-17.10%33.61M
-11.16%16.09M
-18.40%84.11M
-30.43%59.53M
-40.24%40.54M
-48.31%18.1M
-26.44%103.08M
-11.84%85.57M
-0.47%67.84M
Financial expense
9.91%63.06M
133.80%48.34M
21.64%12.42M
20.15%60.97M
58.72%57.38M
-26.01%20.68M
-32.47%10.21M
27.92%50.74M
48.98%36.15M
69.94%27.94M
-Interest expense (Financial expense)
3.55%61.35M
125.54%48.87M
34.93%12.79M
9.43%61.31M
44.17%59.24M
-27.64%21.67M
-33.35%9.48M
47.65%56.03M
73.61%41.09M
87.02%29.95M
-Interest Income (Financial expense)
-708.50%-584.04K
-51.29%-44.26K
-1,033.71%-213.87K
74.26%-97.15K
79.33%-72.24K
84.88%-29.26K
75.29%-18.87K
55.81%-377.46K
24.75%-349.43K
53.78%-193.48K
Research and development
-45.75%3.33M
-39.82%2.21M
-51.33%978.78K
-70.26%7.66M
-69.77%6.14M
-80.14%3.66M
-75.35%2.01M
-34.56%25.76M
-24.88%20.3M
-2.94%18.45M
Credit Impairment Loss
-17.04%-120.02M
-147.61%-120.25M
-533.01%-47.02M
-244.10%-195.9M
-133.68%-102.55M
-153.35%-48.56M
43.03%-7.43M
14.52%-56.93M
-17.60%-43.88M
-28.62%-19.17M
Asset Impairment Loss
74.37%-27.39M
65.39%-27.29M
----
-984.45%-559.7M
-510.85%-106.89M
-351.54%-78.87M
---203.69K
-156.11%-51.61M
-555.02%-17.5M
-1,241.49%-17.47M
Other net revenue
29.14%-147.39M
-16.85%-147.72M
-542.18%-46.78M
-1,359.69%-685.67M
-7,739.83%-207.99M
-285.30%-126.42M
35.50%-7.28M
29.68%-46.97M
83.20%-2.65M
-2,524.77%-32.81M
Fair value change income
----
----
----
--67.63M
----
----
----
----
----
----
Invest income
----
----
----
----
----
----
----
5,332.45%55.19M
5,294,936.94%53.47M
-59,101.29%-595.75K
Asset deal income
-62.74%-495.31K
-12.21%-520.86K
----
58.68%78.55K
-678.28%-304.35K
-981.98%-464.19K
----
-97.64%49.5K
-98.33%52.63K
-98.36%52.63K
Other revenue
-70.30%520.87K
-76.56%346.79K
-29.40%245.69K
-65.09%2.21M
-66.35%1.75M
-66.12%1.48M
-84.54%348.02K
-66.52%6.33M
-64.14%5.21M
-62.08%4.37M
Operating profit
-41.49%-276.63M
-91.88%-238.36M
-142.95%-77.43M
-937.70%-669.71M
-243.94%-195.51M
-343.88%-124.22M
-161.84%-31.87M
-54.81%79.95M
-30.90%135.83M
-68.61%50.93M
Add:Non operating Income
-99.96%30.22K
-99.99%8.06K
-77.94%5.15K
-92.27%764.07K
886.00%81.28M
897.56%81.09M
-88.61%23.35K
542.27%9.89M
1,605.14%8.24M
2,208.39%8.13M
Less:Non operating expense
196.73%3.5M
901.33%3.35M
4,719.49%3.69M
-33.01%12.06M
-88.66%1.18M
-96.60%334.95K
-84.64%76.61K
-10.55%18.01M
261.14%10.4M
878.27%9.85M
Total profit
-142.71%-280.1M
-456.15%-241.71M
-154.09%-81.12M
-1,048.14%-681.01M
-186.33%-115.4M
-188.32%-43.46M
-162.30%-31.93M
-54.63%71.83M
-31.16%133.67M
-69.55%49.21M
Less:Income tax cost
-99.97%6.53K
----
----
-3.41%26.32M
-27.40%22.19M
-116.90%-5.86M
-209.61%-1.11M
2,807.50%27.25M
756.73%30.56M
1,045.65%34.64M
Net profit
-103.58%-280.11M
-542.76%-241.71M
-163.26%-81.12M
-1,686.94%-707.33M
-233.44%-137.59M
-358.13%-37.6M
-161.34%-30.81M
-72.03%44.57M
-45.90%103.11M
-90.81%14.57M
Net profit from continuing operation
-103.58%-280.11M
-542.76%-241.71M
-163.26%-81.12M
-1,686.94%-707.33M
-233.44%-137.59M
-358.13%-37.6M
-161.34%-30.81M
-72.03%44.57M
-45.90%103.11M
-90.81%14.57M
Less:Minority Profit
-356.02%-99.13M
-565.69%-89.13M
-327.93%-33.61M
-249.87%-101.68M
-128.72%-21.74M
-124.41%-13.39M
-122.07%-7.86M
-38.45%67.85M
-19.40%75.68M
-26.48%54.84M
Net profit of parent company owners
-56.21%-180.97M
-530.08%-152.57M
-106.92%-47.51M
-2,502.35%-605.65M
-522.43%-115.85M
39.88%-24.22M
-256.75%-22.96M
-147.40%-23.27M
-71.64%27.43M
-147.95%-40.28M
Earning per share
Basic earning per share
-56.21%-0.5166
-530.25%-0.4355
-107.02%-0.1356
-2,503.61%-1.7288
-522.35%-0.3307
39.91%-0.0691
-256.70%-0.0655
-147.36%-0.0664
-71.63%0.0783
-147.96%-0.115
Diluted earning per share
-56.21%-0.5166
-530.25%-0.4355
-107.02%-0.1356
-2,503.61%-1.7288
-522.35%-0.3307
39.91%-0.0691
-256.70%-0.0655
-147.36%-0.0664
-71.63%0.0783
-147.96%-0.115
Other composite income
170.80%5.39K
145.07%5.39K
Other composite income of parent company owners
----
----
----
----
----
----
----
----
170.80%5.39K
145.07%5.39K
Total composite income
-103.58%-280.11M
-542.76%-241.71M
-163.26%-81.12M
-1,686.94%-707.33M
-233.44%-137.59M
-358.03%-37.6M
-161.39%-30.81M
-72.02%44.57M
-45.90%103.11M
-90.81%14.57M
Total composite income of parent company owners
-56.21%-180.97M
-530.08%-152.57M
-106.92%-47.51M
-2,502.35%-605.65M
-522.35%-115.85M
39.87%-24.22M
-257.22%-22.96M
-147.42%-23.27M
-71.63%27.43M
-147.95%-40.27M
Total composite income of minority owners
-356.02%-99.13M
-565.69%-89.13M
-327.93%-33.61M
-249.87%-101.68M
-128.72%-21.74M
-124.41%-13.39M
-122.07%-7.86M
-38.45%67.85M
-19.40%75.68M
-26.48%54.84M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
--
--
--
--
China Audit Asia Pacific Accounting Firm (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -90.12%101M-84.53%73.65M-56.80%59.09M-25.86%1.2B-28.17%1.02B-52.01%476.01M-74.92%136.79M-31.61%1.62B-21.76%1.42B-23.56%991.85M
Operating revenue -90.12%101M-84.53%73.65M-56.80%59.09M-25.86%1.2B-28.17%1.02B-52.01%476.01M-74.92%136.79M-31.61%1.62B-21.76%1.42B-23.56%991.85M
Other operating revenue -----61.43%2.15M----47.17%8.15M----74.25%5.58M-----59.75%5.54M-----59.30%3.2M
Total operating cost -77.19%230.25M-65.33%164.29M-44.39%89.75M-20.61%1.18B-21.40%1.01B-47.82%473.82M-66.56%161.38M-29.73%1.49B-20.04%1.28B-20.11%908.11M
Operating cost -88.82%96.03M-82.52%69.48M-56.54%54.6M-21.05%1B-22.29%859.11M-47.99%397.4M-69.17%125.65M-30.53%1.27B-21.06%1.11B-23.38%764.04M
Operating tax surcharges -16.73%2.01M-27.81%1.25M-15.94%554.83K-47.23%3.71M-56.84%2.41M-61.37%1.73M-69.00%660.02K-18.46%7.03M-16.09%5.59M-0.98%4.48M
Operating expense -47.45%13.04M-4.12%9.4M7.63%5.1M-29.04%23.59M-20.04%24.82M-61.33%9.81M-67.60%4.74M-48.32%33.24M-38.38%31.04M-19.18%25.36M
Administration expense -11.35%52.78M-17.10%33.61M-11.16%16.09M-18.40%84.11M-30.43%59.53M-40.24%40.54M-48.31%18.1M-26.44%103.08M-11.84%85.57M-0.47%67.84M
Financial expense 9.91%63.06M133.80%48.34M21.64%12.42M20.15%60.97M58.72%57.38M-26.01%20.68M-32.47%10.21M27.92%50.74M48.98%36.15M69.94%27.94M
-Interest expense (Financial expense) 3.55%61.35M125.54%48.87M34.93%12.79M9.43%61.31M44.17%59.24M-27.64%21.67M-33.35%9.48M47.65%56.03M73.61%41.09M87.02%29.95M
-Interest Income (Financial expense) -708.50%-584.04K-51.29%-44.26K-1,033.71%-213.87K74.26%-97.15K79.33%-72.24K84.88%-29.26K75.29%-18.87K55.81%-377.46K24.75%-349.43K53.78%-193.48K
Research and development -45.75%3.33M-39.82%2.21M-51.33%978.78K-70.26%7.66M-69.77%6.14M-80.14%3.66M-75.35%2.01M-34.56%25.76M-24.88%20.3M-2.94%18.45M
Credit Impairment Loss -17.04%-120.02M-147.61%-120.25M-533.01%-47.02M-244.10%-195.9M-133.68%-102.55M-153.35%-48.56M43.03%-7.43M14.52%-56.93M-17.60%-43.88M-28.62%-19.17M
Asset Impairment Loss 74.37%-27.39M65.39%-27.29M-----984.45%-559.7M-510.85%-106.89M-351.54%-78.87M---203.69K-156.11%-51.61M-555.02%-17.5M-1,241.49%-17.47M
Other net revenue 29.14%-147.39M-16.85%-147.72M-542.18%-46.78M-1,359.69%-685.67M-7,739.83%-207.99M-285.30%-126.42M35.50%-7.28M29.68%-46.97M83.20%-2.65M-2,524.77%-32.81M
Fair value change income --------------67.63M------------------------
Invest income ----------------------------5,332.45%55.19M5,294,936.94%53.47M-59,101.29%-595.75K
Asset deal income -62.74%-495.31K-12.21%-520.86K----58.68%78.55K-678.28%-304.35K-981.98%-464.19K-----97.64%49.5K-98.33%52.63K-98.36%52.63K
Other revenue -70.30%520.87K-76.56%346.79K-29.40%245.69K-65.09%2.21M-66.35%1.75M-66.12%1.48M-84.54%348.02K-66.52%6.33M-64.14%5.21M-62.08%4.37M
Operating profit -41.49%-276.63M-91.88%-238.36M-142.95%-77.43M-937.70%-669.71M-243.94%-195.51M-343.88%-124.22M-161.84%-31.87M-54.81%79.95M-30.90%135.83M-68.61%50.93M
Add:Non operating Income -99.96%30.22K-99.99%8.06K-77.94%5.15K-92.27%764.07K886.00%81.28M897.56%81.09M-88.61%23.35K542.27%9.89M1,605.14%8.24M2,208.39%8.13M
Less:Non operating expense 196.73%3.5M901.33%3.35M4,719.49%3.69M-33.01%12.06M-88.66%1.18M-96.60%334.95K-84.64%76.61K-10.55%18.01M261.14%10.4M878.27%9.85M
Total profit -142.71%-280.1M-456.15%-241.71M-154.09%-81.12M-1,048.14%-681.01M-186.33%-115.4M-188.32%-43.46M-162.30%-31.93M-54.63%71.83M-31.16%133.67M-69.55%49.21M
Less:Income tax cost -99.97%6.53K---------3.41%26.32M-27.40%22.19M-116.90%-5.86M-209.61%-1.11M2,807.50%27.25M756.73%30.56M1,045.65%34.64M
Net profit -103.58%-280.11M-542.76%-241.71M-163.26%-81.12M-1,686.94%-707.33M-233.44%-137.59M-358.13%-37.6M-161.34%-30.81M-72.03%44.57M-45.90%103.11M-90.81%14.57M
Net profit from continuing operation -103.58%-280.11M-542.76%-241.71M-163.26%-81.12M-1,686.94%-707.33M-233.44%-137.59M-358.13%-37.6M-161.34%-30.81M-72.03%44.57M-45.90%103.11M-90.81%14.57M
Less:Minority Profit -356.02%-99.13M-565.69%-89.13M-327.93%-33.61M-249.87%-101.68M-128.72%-21.74M-124.41%-13.39M-122.07%-7.86M-38.45%67.85M-19.40%75.68M-26.48%54.84M
Net profit of parent company owners -56.21%-180.97M-530.08%-152.57M-106.92%-47.51M-2,502.35%-605.65M-522.43%-115.85M39.88%-24.22M-256.75%-22.96M-147.40%-23.27M-71.64%27.43M-147.95%-40.28M
Earning per share
Basic earning per share -56.21%-0.5166-530.25%-0.4355-107.02%-0.1356-2,503.61%-1.7288-522.35%-0.330739.91%-0.0691-256.70%-0.0655-147.36%-0.0664-71.63%0.0783-147.96%-0.115
Diluted earning per share -56.21%-0.5166-530.25%-0.4355-107.02%-0.1356-2,503.61%-1.7288-522.35%-0.330739.91%-0.0691-256.70%-0.0655-147.36%-0.0664-71.63%0.0783-147.96%-0.115
Other composite income 170.80%5.39K145.07%5.39K
Other composite income of parent company owners --------------------------------170.80%5.39K145.07%5.39K
Total composite income -103.58%-280.11M-542.76%-241.71M-163.26%-81.12M-1,686.94%-707.33M-233.44%-137.59M-358.03%-37.6M-161.39%-30.81M-72.02%44.57M-45.90%103.11M-90.81%14.57M
Total composite income of parent company owners -56.21%-180.97M-530.08%-152.57M-106.92%-47.51M-2,502.35%-605.65M-522.35%-115.85M39.87%-24.22M-257.22%-22.96M-147.42%-23.27M-71.63%27.43M-147.95%-40.27M
Total composite income of minority owners -356.02%-99.13M-565.69%-89.13M-327.93%-33.61M-249.87%-101.68M-128.72%-21.74M-124.41%-13.39M-122.07%-7.86M-38.45%67.85M-19.40%75.68M-26.48%54.84M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --------------Unqualified opinion----
Auditor --------------China Audit Asia Pacific Accounting Firm (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.